Recent Sentinel Activity

This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.

RSS Feed

URL	Title	Category	Date	Recent Activity
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/ustekinumab-dispensing-patterns-descriptive-analysis	Ustekinumab Dispensing Patterns: A Descriptive Analysis	Analyses	11/24/2020	Ustekinumab Dispensing Patterns: A Descriptive Analysis Analyses 11/24/2020
https://www.sentinelinitiative.org/methods-data-tools/sentinel-national-resource/patient-characteristics-and-utilization-patterns	Patient Characteristics and Utilization Patterns of Short-Acting Recombinant Granulocyte Colony-Stimulating Factor (G-CSF) Biosimilars Compared to Their Reference Product		01/30/2021	Patient Characteristics and Utilization Patterns of Short-Acting Recombinant Granulocyte Colony-Stimulating Factor (G-CSF) Biosimilars Compared to Their Reference Product 01/30/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/covid-19-pregnancy-study-implementation	COVID-19 Pregnancy Study Implementation	Methods, Data, & Tools	02/24/2021	COVID-19 Pregnancy Study Implementation Methods, Data, & Tools 02/24/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/pregnancy-among-women-heart-failure-descriptive-analysis	Pregnancy among Women with Heart Failure: A Descriptive Analysis	Modular Programs	03/07/2021	Pregnancy among Women with Heart Failure: A Descriptive Analysis Modular Programs 03/07/2021
https://www.sentinelinitiative.org/methods-data-tools/sentinel-national-resource/identifying-prescribing-cascades-alzheimers-disease	Identifying Prescribing Cascades in Alzheimer's Disease and Related Dementias: The Calcium Channel Blocker-Diuretic Prescribing Cascade		03/14/2021	Identifying Prescribing Cascades in Alzheimer's Disease and Related Dementias: The Calcium Channel Blocker-Diuretic Prescribing Cascade 03/14/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/venous-and-arterial-thromboembolism-among-new-users-nuvaring	Venous and Arterial Thromboembolism among New Users of NuvaRing and Other Combined Hormonal Contraceptives: A Descriptive Analysis	Modular Programs	03/25/2021	Venous and Arterial Thromboembolism among New Users of NuvaRing and Other Combined Hormonal Contraceptives: A Descriptive Analysis Modular Programs 03/25/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/lymphoma-risk-following-guselkumab-risankizumab-or	Lymphoma Risk following Guselkumab, Risankizumab, or Tildrakizumab Use: A Descriptive Analysis	Modular Programs	03/30/2021	Lymphoma Risk following Guselkumab, Risankizumab, or Tildrakizumab Use: A Descriptive Analysis Modular Programs 03/30/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/adbry-tralokinumab	Assessment of ARIA Sufficiency: Adbry (tralokinumab)	Sufficiency Assessments	04/08/2021	Assessment of ARIA Sufficiency: Adbry (tralokinumab) Sufficiency Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2016	Duration of Follow Up for New Molecular Entities Approved in 2016	Analyses	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2016 Analyses 04/16/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2014-and	Duration of Follow Up for New Molecular Entities Approved in 2014 and 2015	Analyses	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2014 and 2015 Analyses 04/16/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2010-2012	Duration of Follow Up for New Molecular Entities Approved in 2010, 2012, and 2013	Analyses	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2010, 2012, and 2013 Analyses 04/16/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2008-and	Duration of Follow Up for New Molecular Entities Approved in 2008 and 2009	Analyses	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2008 and 2009 Analyses 04/16/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2005-2006	Duration of Follow Up for New Molecular Entities Approved in 2005, 2006, and 2007	Analyses	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2005, 2006, and 2007 Analyses 04/16/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2011	Duration of Follow Up for New Molecular Entities Approved in 2011	Analyses	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2011 Analyses 04/16/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/utilization-hydroxyprogesterone-caproate-among-pregnancies	Utilization of Hydroxyprogesterone Caproate among Pregnancies with Live Birth Deliveries in the Sentinel Distributed Database	Publications and Presentations	04/29/2021	Utilization of Hydroxyprogesterone Caproate among Pregnancies with Live Birth Deliveries in the Sentinel Distributed Database Publications and Presentations 04/29/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/treescan-pregnancy	TreeScan in Pregnancy	Methods, Data, & Tools	07/14/2021	TreeScan in Pregnancy Methods, Data, & Tools 07/14/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2017	Duration of Follow Up for New Molecular Entities Approved in 2017: A Descriptive Analysis	Analyses	08/13/2021	Duration of Follow Up for New Molecular Entities Approved in 2017: A Descriptive Analysis Analyses 08/13/2021
https://www.sentinelinitiative.org/methods-data-tools/sentinel-national-resource/bbcic-research-network-analysis-first-cycle	BBCIC Research Network Analysis of First-Cycle Prophylactic G-CSF Use in Patients Treated with High Neutropenia Risk Chemotherapy		08/16/2021	BBCIC Research Network Analysis of First-Cycle Prophylactic G-CSF Use in Patients Treated with High Neutropenia Risk Chemotherapy 08/16/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/use-mobile-app-capture-supplemental-health-information-0	Use of a Mobile App to Capture Supplemental Health Information During Pregnancy: Implications for Clinical Research	Publications and Presentations	08/23/2021	Use of a Mobile App to Capture Supplemental Health Information During Pregnancy: Implications for Clinical Research Publications and Presentations 08/23/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/no-differential-risk-cutaneous-small-vessel-vasculitis-oral	No Differential Risk of Cutaneous Small Vessel Vasculitis with Oral Anticoagulant Use Among Patients with Atrial Fibrillation	Publications and Presentations	08/24/2021	No Differential Risk of Cutaneous Small Vessel Vasculitis with Oral Anticoagulant Use Among Patients with Atrial Fibrillation Publications and Presentations 08/24/2021
https://www.sentinelinitiative.org/methods-data-tools/software-packages-toolkits/making-medicaid-data-more-accessible-through-common	Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs	Methods, Data, & Tools	09/24/2021	Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs Methods, Data, & Tools 09/24/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/use-multiple-sclerosis-drugs-among-pregnant-women-live-birth	Use of Multiple Sclerosis Drugs Among Pregnant Women with Live-Birth Deliveries: A Descriptive Analysis	Assessments	10/20/2021	Use of Multiple Sclerosis Drugs Among Pregnant Women with Live-Birth Deliveries: A Descriptive Analysis Assessments 10/20/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/reliable-insights-regarding-medication-outcomes-real-world	Reliable Insights Regarding Medication Outcomes From Real World Data – Key Principles of an Evidence Generation Framework	Publications and Presentations	11/01/2021	Reliable Insights Regarding Medication Outcomes From Real World Data – Key Principles of an Evidence Generation Framework Publications and Presentations 11/01/2021
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-sentinel-community-building-and-outreach-center	2022 Sentinel Community Building and Outreach Center Webinar Series	Sentinel Initiative Events	11/23/2021	2022 Sentinel Community Building and Outreach Center Webinar Series Sentinel Initiative Events 11/23/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/intentional-self-harm-and-hospitalized-depression-following	Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis	Analyses	12/15/2021	Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis Analyses 12/15/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/intentional-self-harm-and-hospitalized-depression-0	Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis (A Follow-up to a Previous Analysis)	Analyses	12/15/2021	Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis (A Follow-up to a Previous Analysis) Analyses 12/15/2021
https://www.sentinelinitiative.org/methods-data-tools/sentinel-common-data-model/data-quality-review-and-characterization-programs	Data Quality Review and Characterization Programs	Methods, Data, & Tools	12/16/2021	Data Quality Review and Characterization Programs Methods, Data, & Tools 12/16/2021
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-sentinel-innovation-and-methods-seminar-series	2022 Sentinel Innovation and Methods Seminar Series	Sentinel Initiative Events	01/01/2022	2022 Sentinel Innovation and Methods Seminar Series Sentinel Initiative Events 01/01/2022
https://www.sentinelinitiative.org/studies/drugs/zoloft-sertraline-0	Zoloft (Sertraline) & Intentional Self-Harm and Hospitalized Depression	Studies	01/04/2022	Zoloft (Sertraline) & Intentional Self-Harm and Hospitalized Depression Studies 01/04/2022
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/thromboembolic-stroke-algorithm-defined-1	Thromboembolic Stroke Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis"	Methods, Data, & Tools	01/06/2022	Thromboembolic Stroke Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis" Methods, Data, & Tools 01/06/2022
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/gastrointestinal-bleeding-algorithm-defined-0	Gastrointestinal Bleeding Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis"	Methods, Data, & Tools	01/06/2022	Gastrointestinal Bleeding Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis" Methods, Data, & Tools 01/06/2022
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/major-extracranial-bleeding-algorithm-defined-1	Major Extracranial Bleeding Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis"	Methods, Data, & Tools	01/06/2022	Major Extracranial Bleeding Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis" Methods, Data, & Tools 01/06/2022
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/intracranial-hemorrhage-algorithm-defined-1	Intracranial Hemorrhage Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis"	Methods, Data, & Tools	01/06/2022	Intracranial Hemorrhage Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis" Methods, Data, & Tools 01/06/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2017-updated	Duration of Follow Up for New Molecular Entities Approved in 2017: An Updated Descriptive Analysis	Analyses	01/21/2022	Duration of Follow Up for New Molecular Entities Approved in 2017: An Updated Descriptive Analysis Analyses 01/21/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2019	Duration of Follow Up for New Molecular Entities Approved in 2019: A Descriptive Analysis	Analyses	01/26/2022	Duration of Follow Up for New Molecular Entities Approved in 2019: A Descriptive Analysis Analyses 01/26/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/evaluating-confounding-control-estimations-influenza-0	Evaluating Confounding Control in Estimations of Influenza Antiviral Effectiveness in Electronic Health Plan Data	Publications and Presentations	02/02/2022	Evaluating Confounding Control in Estimations of Influenza Antiviral Effectiveness in Electronic Health Plan Data Publications and Presentations 02/02/2022
https://www.sentinelinitiative.org/studies/drugs/prenatal-tests	Prenatal Tests & Stillbirth	Studies	02/03/2022	Prenatal Tests & Stillbirth Studies 02/03/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/n-nitrosodimethylamine-ndma-contaminated-and-non-ndma	N‐nitrosodimethylamine (NDMA)‐Contaminated and Non‐NDMA‐Contaminated Valsartan Use: A Descriptive Analysis	Analyses	02/18/2022	N‐nitrosodimethylamine (NDMA)‐Contaminated and Non‐NDMA‐Contaminated Valsartan Use: A Descriptive Analysis Analyses 02/18/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/tofacitinib-disease-modifying-anti-rheumatic-drugs-dmards	Tofacitinib, Disease-Modifying Anti-Rheumatic Drugs (DMARDs) and Tumor Necrosis Factor Inhibitors (TNFi) Use: A Descriptive Analysis	Analyses	02/24/2022	Tofacitinib, Disease-Modifying Anti-Rheumatic Drugs (DMARDs) and Tumor Necrosis Factor Inhibitors (TNFi) Use: A Descriptive Analysis Analyses 02/24/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/bleeding-events-and-venous-thromboembolism-vte-following	Bleeding Events and Venous Thromboembolism (VTE) following Enoxaparin Use: A Descriptive Analysis	Analyses	02/25/2022	Bleeding Events and Venous Thromboembolism (VTE) following Enoxaparin Use: A Descriptive Analysis Analyses 02/25/2022